Use of intravenous immunoglobulin therapy in autoimmune blistering diseases

International Immunopharmacology
A Razzaque Ahmed

Abstract

Autoimmune mucocutaneous blistering diseases (AMBD) are an interesting group of rare diseases that affect the mucous membranes and the skin and are frequently or potentially fatal. The clinical presentation is significantly variable, as is the course and prognosis. The immunopathology is well characterized and the target antigens to which the autoantibodies are directed have been studied by various investigators. A significant majority of the patients respond to conventional therapy, which consists of high-dose long-term systemic corticosteroids and immunosuppressive agents. This treatment program has significantly improved the prognosis in many patients. In such patients, significant side effects of the drugs may appear and produce a very poor quality of life. In patients with progressive diseases, especially those with mucous membrane pemphigoid, the significant sequela; such as blindness, aphonia, and stenosis of the anal and vaginal canals can occur. In several patients treated with conventional immunosuppressive therapy, death occurs as a consequence of prolonged immune suppression leading to opportunistic infections. In this manuscript, the published data on the use of immunoglobulins intravenous (IGIV) in patients with A...Continue Reading

References

May 1, 1977·Archives of Dermatology·J R Person, R S Rogers
Nov 1, 1977·Archives of Dermatology·M MeurerR E Jordon
Nov 1, 1979·The British Journal of Dermatology·J A Savin
Jun 1, 1976·The British Journal of Dermatology·T Piamphongsant
Jan 1, 1976·Dermatologica·T Piamphongsant, S Ausawamongkonpan
Dec 1, 1992·Archives of Dermatology·A G Pandya, R D Sontheimer
Apr 1, 1992·Journal of the American Academy of Dermatology·V A Venning, F Wojnarowska
May 1, 1990·Journal of the American Academy of Dermatology·A Milligan, P E Hutchinson
Feb 1, 1990·Journal of the American Academy of Dermatology·P HumbertP Agache
Dec 1, 1985·Annals of Internal Medicine·W GodardG Rifle
Dec 1, 1988·The Journal of Clinical Investigation·J R StanleyD Roop
Apr 1, 1989·Journal of the American Academy of Dermatology·G Tappeiner, A Steiner
Jan 1, 1989·The Australasian Journal of Dermatology·K KyriakisJ Stratigos
Sep 1, 1988·The Annals of Otology, Rhinology, and Laryngology·R D HansonR S Rogers
Dec 1, 1986·Pediatric Dermatology·S K JonesD A Norris
May 29, 1967·JAMA : the Journal of the American Medical Association·R E JordonW F Lever
Sep 1, 1974·Oral Surgery, Oral Medicine, and Oral Pathology·S PisantiL N Posner
Aug 1, 1972·Archives of Dermatology·S F BeanM Levine
Aug 1, 1973·Archives of Dermatology·P Dantzig
Nov 1, 1972·Archives of Dermatology·L S KrainV D Newcomer
Apr 1, 1971·Archives of Otolaryngology·G Shklar, P L McCarthy
Jul 1, 1969·Annals of Internal Medicine·A Ebringer, I R Mackay
Apr 19, 1984·The New England Journal of Medicine·D T WoodleyW R Gammon
Sep 1, 1984·Archives of Dermatology·J Siegel, W H Eaglstein
Nov 1, 1984·Journal of the American Academy of Dermatology·W R GammonC E Wheeler
Dec 1, 1982·Journal of the American Academy of Dermatology·R S RogersS H Nightingale
Jul 1, 1981·Journal of the American Academy of Dermatology·R F PalestineC H Dicken
Aug 1, 1982·Journal of the American Academy of Dermatology·A R Ahmed, R Moy
Sep 1, 1980·Archives of Dermatology·D G SimonR Zarbo
Nov 1, 1994·Journal of the American Academy of Dermatology·J B CaldwellW D James
Dec 1, 1994·Archives of Dermatology·N Domloge-HultschK B Yancey
May 1, 1994·Journal of the American Academy of Dermatology·M LapidothM Sandbank
Aug 1, 1993·Journal of the American Academy of Dermatology·F MeierG Rassner
Jun 1, 1993·Journal of the American Academy of Dermatology·M L ChaffinsD P Fivenson
Dec 1, 1995·The British Journal of Dermatology·G MesserM Meurer
May 1, 1996·The British Journal of Dermatology·T ItohT Horio
Jul 1, 1996·The British Journal of Dermatology·A P Bewley, M Keefe
Jan 1, 1996·International Ophthalmology Clinics·Q D Nguyen, C S Foster
Feb 1, 1997·Journal of the American Academy of Dermatology·H KoflerP Fritsch
Feb 22, 1997·Lancet·M BöhmT Luger
Sep 25, 1997·Archives of Dermatology·C Callot-MellotC Prost
Feb 12, 1998·The British Journal of Dermatology·M L UrcelayW S Douglas
Feb 12, 1998·The British Journal of Dermatology·R S DaweJ Ferguson
Jan 22, 1998·Journal of the American Geriatrics Society·Z Tehranchi-NiaA R Ahmed

❮ Previous
Next ❯

Citations

Jun 27, 2009·Clinical Reviews in Allergy & Immunology·Norito IshiiRalf J Ludwig
May 8, 2009·Pediatric Dermatology·Adam Asarch, A Razzaque Ahmed
Feb 16, 2008·Journal of Autoimmune Diseases·Masha Fridkis-Hareli
Oct 7, 2014·Indian Journal of Dermatology·Virendra N SehgalAnanta Khurana
May 9, 2012·Immunology and Allergy Clinics of North America·Shien-Ning Chee, Dédée F Murrell
Sep 20, 2011·Dermatologic Clinics·Shien-Ning Chee, Dédée F Murrell
Feb 20, 2008·Immunology and Allergy Clinics of North America·Samih ElchahalDavid S Chu
Apr 5, 2008·Ophthalmology·Michele D MignognaGiulio Bonovolontà
Mar 23, 2007·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Junu OjhaJoseph Katz
Oct 17, 2013·The Journal of Dermatology·Tamihiro KawakamiTakashi Hashimoto
Dec 15, 2010·Journal of the European Academy of Dermatology and Venereology : JEADV·A R Ahmed, H M Gürcan
Jan 5, 2011·The Australasian Journal of Dermatology·Saxon D SmithAlan Cooper
Nov 4, 2009·Clinical and Experimental Immunology·H-P HartungS Jolles
Feb 6, 2007·International Immunopharmacology·Elisabeth MaierHans Peter Schwarz
Nov 1, 2007·Dermatologic Therapy·Anthony P Fernandez, Francisco A Kerdel
Jun 13, 2020·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Elena CalabriaMichele D Mignogna
Feb 9, 2011·Clinical Neuropharmacology·Irina ElovaaraBirgit Reipert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.